Atlas Trials

CNI-1493 for Treatment of Moderate to Severe Crohn's Disease

Clinical trial NCT00038766 · TERMINATED

Trial details

NCT number
NCT00038766
Sponsor
Ferring Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn Disease
Start date
2002-06-01
Primary completion
2003-06-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.